STAT+: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment
Now that Eli Lilly is cutting prices on some of its insulin products, U.S. Sen….
Category: Congress
With a $11 billion price tag, the White House pitches a plan to end hepatitis C
WASHINGTON – The Biden administration is calling on Congress to fund a more than $11…
Pfizer CEO Albert Bourla maxed out campaign contributions to Dr. Oz ahead of midterm elections
WASHINGTON — Pfizer CEO Albert Bourla made the maximum possible campaign contribution to Mehmet Oz…
STAT+: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines
WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive…
Revamped Covid panel argues for research limits, even bans
WASHINGTON — Pathogen-altering research is back under fire here, as Republican lawmakers argue it should…
Biden proposes expanding Medicare drug negotiation program
WASHINGTON — The Biden administration will propose expanding Democrats’ new drug pricing law by allowing…
STAT+: From industry ‘greed’ to workforce shortages, Sanders and Cassidy lay out health committee agenda
The Senate finally made long-expected committee assignments official on Thursday, kickstarting a new session for…
STAT+: New York’s hospitals are poised for political power this Congress
WASHINGTON — The new Democratic leadership team in Congress is pretty much the New York…
STAT+: Warren urges the FTC to scrutinize two pharma mergers over “anti-competitive” practices
In her latest bid to address prescription drug prices, U.S. Sen. Elizabeth Warren (D-Mass.) is…
After nearly 4 years of deliberation, FDA punts on how to regulate CBD
WASHINGTON — The FDA is giving up on trying to figure out a way to…
STAT+: The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals
WASHINGTON — Congress just boosted the FDA’s authority over the post-market clinical trials that are…
STAT+: Liquid-biopsy firm Grail is spending more than ever lobbying Congress
Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the…
STAT+: Health groups like AHA, PhRMA channeled millions into end-of-year legislative debates
WASHINGTON — Health care groups and their lobbyists spent big in the last few months…
Opinion: Biopharma leaders helped save democracy. Now what?
The rule of law must be upheld for free societies and free markets to flourish,…
STAT+: Congressional Medicare advisers warn of higher drug prices, despite new price negotiation
WASHINGTON — Despite the pharmaceutical industry’s loud complaints to the contrary, the new law directing…
Biden Covid adviser David Kessler to exit as pandemic response winds down
WASHINGTON — David Kessler, the D.C. veteran who guided government dispatches of millions of Covid-19…
STAT+: HHS will seek more input on its new Medicare drug price negotiations
WASHINGTON — The Department of Health and Human Services is gearing up to start releasing…
Will America’s public health reckoning ever come?
WASHINGTON — After 9/11, Congress created an entirely new government agency to address the threat of…
STAT+: HHS will decide how to resolve $1 billion in payments for 340B hospitals
WASHINGTON — The Department of Health and Human Services will get to decide how to…
Still fuming over the federal Covid response, Republicans redirect the House coronavirus committee
WASHINGTON — The House’s coronavirus committee will continue in a Republican-controlled chamber — but with…
STAT+: Rep. Jason Smith and the other Republicans leading health policy in the House
Rep. Jason Smith of Missouri will helm the powerful House Ways & Means Committee this…
Officials in Nebraska, South Dakota, Oklahoma begin to probe prisons’ hepatitis C treatment efforts
WASHINGTON — Members of Congress, state legislators, regulators, and legal advocates are calling on prisons…
STAT+: 3 drug pricing issues to watch in 2023
WASHINGTON — The legislative saga on drug pricing is mostly over for now, but drug…
STAT+: 3 trends to watch in hospitals and health insurance in 2023
For almost three years, hospitals and health insurers have been riding the waves of the…
FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation
Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug…
STAT+: ‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol
WASHINGTON — The Food and Drug Administration’s review and approval of a controversial Alzheimer’s drug…
After nine months, an update on NIH’s long Covid research
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Amid dire maternal mortality rates, Congress falls short on Medicaid postpartum care
Last week, the state of Texas issued a long-awaited report that found at least 118…
Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness
WASHINGTON — Leaders in Congress have reached a sweeping deal to ease Medicare pay cuts to…
STAT+: AbbVie exits major pharmaceutical industry lobbying groups
WASHINGTON — The maker of one of the world’s most profitable medicines is exiting the…
STAT+: Nine in 10 health care companies with financial stress are owned by private equity
Almost 90% of the health care companies deemed to be under financial stress by a…
STAT+: New Biden changes to Obamacare coverage for generics splits the industry
WASHINGTON — The Biden administration signaled Monday that it will require health plans on federal…
STAT+: Medicare chief: ‘Door is really open’ on coverage for new Alzheimer’s drug
Medicare is willing to re-evaluate its coverage of Alzheimer’s drugs in light of a new…
STAT+: Congress has a chance to close the FDA’s Theranos loophole
WASHINGTON – Theranos, and the company’s notoriously inaccurate blood tests, could potentially have been stopped…
.jpg)
STAT+: ARPA-H’s new director wants to go on a hiring spree
President Biden’s new health agency with a sweeping mandate to cure some of the system’s…
STAT+: FDA chief calls agency’s food program ‘under-supported, under-resourced’
FDA Commissioner Robert Califf said the food side of the agency needs more attention Wednesday,…
Congress has its sights set too low on addiction, advocates charge
Judging by lawmakers’ words, addiction might be the most bipartisan topic in Washington. For years,…
Opinion: Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics
Congress is considering two measures that modernize tools the Food and Drug Administration uses to…
Opinion: Breakthrough Therapies Act: Good idea, wrong solution
The Breakthrough Therapies Act, recently proposed by Senators Rand Paul (R-Ky.) and Cory Booker (D-N.J.)…
Opinion: Congress: Close the gap between funding for nutrition research and the toll diet-related disease takes on Americans
You are what you eat. Every year, new scientific discoveries make clear that food is…
Opinion: Better lab test standards can ensure precision medicine is truly precise
Cancer is becoming less deadly in America. According to the recently released Annual Report to…
STAT+: Patient groups push federal government to enforce health care price estimates
People don’t receive bills after going to a grocery store or a mechanic’s shop. They…
Opinion: Congress: Confront the superbug crisis and pass PASTEUR
By 2050, drug-resistant infections caused by “superbugs” could kill 10 million people each year around…
In a Republican-led House, anti-science probes top the agenda
WASHINGTON — The Covid-19 investigations are coming. When Republicans take control of the House of Representatives…
A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees
WASHINGTON — The outlook for the White House’s health and science priorities just got a…
In Arizona’s race for governor, Kari Lake fans Republican fury over Fauci, fentanyl and gender-affirming care
TEMPE, AZ. — On a windy, warm November night, thousands of Arizona Democrats lined the…
STAT+: Amid concerns over U.S. democracy, pharma helped finance committees that support election deniers
As Americans head to the polls, some candidates continue to deny the results of the…
.jpg)
Medicare’s midterm punts, MA marketing schemes, and a closer look at the Abiomed deal
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
Health and science are on the ballot this election. Here’s what we’re watching
WASHINGTON — The midterm elections this year are centered on weighty topics: the economy looms…
STAT+: A ‘blank check’: Bill to boost antibiotic development blasted as a ‘flawed’ giveaway to pharma
Amid mounting concern over antibiotic resistance, a coalition of academics and advocacy groups is urging…